Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center

• Hakan Göker,
• Olgu Erkin Çınar,
• Haluk Demiroğlu,
• Ümit Yavuz Malkan,
• Elifcan Aladağ Karakulak,
• Yahya Büyükaşık

Affiliations

Hakan Göker

Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Türkiye

Olgu Erkin Çınar

Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Türkiye

Haluk Demiroğlu

Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Türkiye

Ümit Yavuz Malkan

Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Türkiye

Elifcan Aladağ Karakulak

Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Türkiye

Yahya Büyükaşık

Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Türkiye